The primary objective is to demonstrate the effectiveness at 30-days post heart transplantation, and an acceptable long-term safety profile of the XVIVO Heart Preservation System.
What is the full name of this clinical trial?
A Prospective, Multi-center, Single-Arm, Open- label Study of Hearts Transplanted after Non-Ischemic Heart PRESERVation from Extended Donors